Article Text

Download PDFPDF
Flavour capsule cigarettes continue to experience strong global growth
  1. Crawford Moodie1,
  2. James F Thrasher2,
  3. Yoo Jin Cho2,
  4. Joaquin Barnoya3,
  5. Frank J Chaloupka4
  1. 1 Institute for Social Marketing, School of Health Sciences and Sport, University of Stirling, Stirling, UK
  2. 2 Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA
  3. 3 Unidad de Cirugia Cardiovascular de Guatemala, Ciudad de Guatemala, Guatemala
  4. 4 Department of Economics, Institute for Health Research and Policy, University of Illinois, Chicago, Illinois, USA
  1. Correspondence to Dr Crawford Moodie, Institute for Social Marketing, School of Health Sciences and Sport, University of Stirling, Stirlingshire FK9 4LA, UK; c.s.moodie{at}stir.ac.uk

Statistics from Altmetric.com

Cigarettes with flavour-changing capsules in the filter, a continuing success story for tobacco companies, have grown exponentially since being introduced in 2007. The global capsule market is estimated to be 150 billion sticks in 2017.1 We provide an update on the capsule market since 2014.2 From this time, capsule cigarettes have been introduced in new markets in Europe (Croatia, Spain), Africa (Tunisia), Latin America (Bolivia, Ecuador, Uruguay) and Asia (China, India, Philippines, Thailand, Vietnam).3 They are the fastest growing segment of the combustible market,4 with market share increasing between 2014 and 2017 in 52 of the 67 countries where they are sold and monitored by tobacco analyst Euromonitor.3 These products now have market share greater than 10% in four European countries (UK, Hungary, Ireland, Poland), and have increased 12% in the Middle East and Africa.1 The five most popular capsule markets remain in Latin America (see figure 1), with market share increasing by at least 40% …

View Full Text

Footnotes

  • Contributors CM drafted the article, with help from JFT, YJC, JB and FJC. All authors approved the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.